265 related articles for article (PubMed ID: 32019406)
21. Individual non-esterified fatty acids and incident atrial fibrillation late in life.
Pellegrini CN; Buzkova P; Lichtenstein AH; Matthan NR; Ix JH; Siscovick DS; Heckbert SR; Tracy RP; Mukamal KJ; Djoussé L; Kizer JR
Heart; 2021 Nov; 107(22):1805-1812. PubMed ID: 33483356
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death.
Schrage B; Geelhoed B; Niiranen TJ; Gianfagna F; Vishram-Nielsen JKK; Costanzo S; Söderberg S; Ojeda FM; Vartiainen E; Donati MB; Magnussen C; Di Castelnuovo A; Camen S; Kontto J; Koenig W; Blankenberg S; de Gaetano G; Linneberg A; Jørgensen T; Zeller T; Kuulasmaa K; Tunstall-Pedoe H; Hughes M; Iacoviello L; Salomaa V; Schnabel RB
J Am Heart Assoc; 2020 May; 9(9):e015218. PubMed ID: 32351154
[TBL] [Abstract][Full Text] [Related]
23. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.
Lamprea-Montealegre JA; Zelnick LR; Shlipak MG; Floyd JS; Anderson AH; He J; Christenson R; Seliger SL; Soliman EZ; Deo R; Ky B; Feldman HI; Kusek JW; deFilippi CR; Wolf MS; Shafi T; Go AS; Bansal N;
J Am Heart Assoc; 2019 Aug; 8(15):e012200. PubMed ID: 31379242
[TBL] [Abstract][Full Text] [Related]
24. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.
Macheret F; Bartz TM; Djousse L; Ix JH; Mukamal KJ; Zieman SJ; Siscovick DS; Tracy RP; Heckbert SR; Psaty BM; Kizer JR
Heart; 2015 Sep; 101(17):1368-74. PubMed ID: 25855796
[TBL] [Abstract][Full Text] [Related]
25. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
Heart; 2017 Aug; 103(16):1271-1277. PubMed ID: 28255099
[TBL] [Abstract][Full Text] [Related]
26. Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.
Magnani JW; Moser CB; Murabito JM; Sullivan LM; Wang N; Ellinor PT; Vasan RS; Benjamin EJ; Coviello AD
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):307-12. PubMed ID: 24610804
[TBL] [Abstract][Full Text] [Related]
27. Comparative investigation of sphingoid bases and fatty acids in ceramides and sphingomyelins from human ovarian malignant tumors and normal ovary.
Rylova SN; Somova OG; Dyatlovitskaya EV
Biochemistry (Mosc); 1998 Sep; 63(9):1057-60. PubMed ID: 9795275
[TBL] [Abstract][Full Text] [Related]
28. Protein Biomarkers and Risk of Atrial Fibrillation: The FHS.
Staerk L; Preis SR; Lin H; Lubitz SA; Ellinor PT; Levy D; Benjamin EJ; Trinquart L
Circ Arrhythm Electrophysiol; 2020 Feb; 13(2):e007607. PubMed ID: 31941368
[TBL] [Abstract][Full Text] [Related]
29. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
30. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
31. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.
Fu S; Jiao J; Guo Y; Zhu B; Luo L
BMC Geriatr; 2019 Feb; 19(1):56. PubMed ID: 30819103
[TBL] [Abstract][Full Text] [Related]
32. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
[TBL] [Abstract][Full Text] [Related]
33. Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.
Li X; Gao L; Wang Z; Guan B; Guan X; Wang B; Han X; Xiao X; Waleed KB; Chandran C; Wu S; Xia Y
Clin Cardiol; 2018 Mar; 41(3):314-320. PubMed ID: 29575115
[TBL] [Abstract][Full Text] [Related]
34. Proteomics Profiling and Risk of New-Onset Atrial Fibrillation: Framingham Heart Study.
Ko D; Benson MD; Ngo D; Yang Q; Larson MG; Wang TJ; Trinquart L; McManus DD; Lubitz SA; Ellinor PT; Vasan RS; Gerszten RE; Benjamin EJ; Lin H
J Am Heart Assoc; 2019 Mar; 8(6):e010976. PubMed ID: 30841775
[TBL] [Abstract][Full Text] [Related]
35. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men.
Virtanen JK; Mursu J; Voutilainen S; Tuomainen TP
Circulation; 2009 Dec; 120(23):2315-21. PubMed ID: 19933935
[TBL] [Abstract][Full Text] [Related]
36. Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
Lind L; Sundström J; Stenemo M; Hagström E; Ärnlöv J
Heart; 2017 Mar; 103(5):377-382. PubMed ID: 27609943
[TBL] [Abstract][Full Text] [Related]
37. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
39. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
40. Posttraumatic Stress Disorder and Risk for Early Incident Atrial Fibrillation: A Prospective Cohort Study of 1.1 Million Young Adults.
Rosman L; Lampert R; Ramsey CM; Dziura J; Chui PW; Brandt C; Haskell S; Burg MM
J Am Heart Assoc; 2019 Oct; 8(19):e013741. PubMed ID: 31564191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
